Ion Beam Applications SA IBA ( (GB:0GZK) ) just unveiled an update.
Ion Beam Applications SA announced a transparency notification due to a decrease in its share participation, dropping below the 2% threshold in voting rights as per the law of May 2, 2007. This change reflects a transfer of shares or voting rights, impacting the company’s transparency obligations and potentially affecting stakeholder perceptions of its market positioning.
More about Ion Beam Applications SA IBA
IBA (Ion Beam Applications S.A.) is a global leader in particle accelerator technology, primarily providing proton therapy solutions for cancer treatment, which is the most advanced form of radiotherapy. The company also operates in industrial sterilization, radiopharmacy, and dosimetry, with headquarters in Louvain-la-Neuve, Belgium, and a workforce of about 2,000 employees globally. IBA is recognized as a certified B Corporation, indicating its commitment to high social and environmental standards.
YTD Price Performance: 1.95%
Average Trading Volume: 789
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €400.4M
For detailed information about 0GZK stock, go to TipRanks’ Stock Analysis page.